Incretin Enhancers/Mimetics
31 - 45 of
82 Results
Sort Results:
Article:
Nesina (nes-SEE-na, alogliptin) will compete in a crowded market of gliptins, or DPP-4 inhibitors, for type 2 diabetes
August 2013
Article:
more emphasis on preventing and treating hypoglycemia in patients with type 2 diabetes
June 2013